Michael G Kauffman Selected Research

Michael G Kauffman Research Topics

10	Multiple Myeloma 11/2022 - 01/2019
7	Neoplasms (Cancer) 01/2022 - 10/2013
3	Fatigue 01/2022 - 01/2020
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2021
2	Nausea 01/2022 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 11/2020
2	Thrombocytopenia (Thrombopenia) 11/2020 - 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 12/2023
1	Liposarcoma 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	COVID-19 01/2021
1	Cytokine Release Syndrome 01/2021
1	Frailty 01/2021
1	Pneumonia (Pneumonitis) 11/2020
1	Diarrhea 01/2020
1	Hyponatremia 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Neutropenia 01/2020
1	Vomiting 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017
1	Mesothelioma 05/2015
1	Melanoma (Melanoma, Malignant) 07/2014
1	Breast Neoplasms (Breast Cancer) 03/2014
1	Triple Negative Breast Neoplasms 03/2014
1	Splenomegaly 10/2013
1	Disease Progression 10/2013
1	Philadelphia Chromosome 10/2013
1	Pain (Aches) 10/2013
1	Leukemia 10/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2013
1	Blast Crisis (Blast Phase) 10/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2013

18	selinexorIBA 12/2023 - 10/2013
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2019
5	Bortezomib (Velcade)FDA Link 01/2022 - 11/2020
4	Exportin 1 ProteinIBA 01/2021 - 05/2015
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 12/2023 - 03/2014
2	EltanexorIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2013
2	SurvivinIBA 05/2015 - 03/2014
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2022
1	B-Cell Maturation AntigenIBA 11/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Proteasome InhibitorsIBA 11/2020
1	Thrombopoietin ReceptorsIBA 01/2020
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2020
1	Neurokinin-1 Receptor AntagonistsIBA 01/2020
1	Olanzapine (Zyprexa)FDA Link 01/2020
1	Serotonin 5-HT3 Receptor AntagonistsIBA 01/2020
1	CannabinoidsIBA 01/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	MegestrolIBA 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020
1	SodiumIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 10/2017
1	verdinexorIBA 07/2014
1	Estrogen ReceptorsIBA 03/2014
1	KPT-251IBA 03/2014
1	KPT-185IBA 03/2014
1	KPT-276IBA 03/2014
1	RNA (Ribonucleic Acid)IBA 10/2013
1	Karyopherins (Importin)IBA 10/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2013
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 10/2013
1	Tyrosine Kinase InhibitorsIBA 10/2013
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 10/2013

10	Therapeutics 12/2023 - 10/2013
2	Drug Therapy (Chemotherapy) 12/2023 - 07/2014
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2020